DiabetesHealth – FDA Approves Dexcom G4 Platinum CGM Use for Children 2-17

Feature NNN - Dexcom dT53

The U.S. Food and Drug Administration has approved the expanded use of the Dexcom G4 Platinum Continuous Glucose Monitoring System for patients with diabetes ages 2 to 17 years. The G4 Platinum System, which monitors blood glucose levels in people with diabetes, had been approved for patients ages 18 and older.

Read more

Posted in Glucose & Insulin Type I